Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
HYDROMORPHONE HP 10 10MG SOLUTION Resolved 2023-08-07 2023-08-15 201259
HYDROMORPHONE HP 10 10MG SOLUTION Resolved 2022-12-28 2023-01-19 179580
HYDROMORPHONE HP 50 50MG SOLUTION Resolved 2022-07-06 2022-10-20 164207
HYDROMORPHONE HP FORTE INJECTION 1000MG SOLUTION Resolved 2023-06-05 2025-04-28 193713
HYDROMORPHONE HP FORTE INJECTION 100MG SOLUTION Resolved 2017-03-14 2017-11-28 2616
HYDROMORPHONE HYDROCHLORIDE INJECTION USP 2MG SOLUTION Resolved 2023-08-29 2023-08-30 203181
HYDROMORPHONE HYDROCHLORIDE INJECTION USP 2MG SOLUTION Resolved 2024-01-08 2024-02-01 215339
HYDROMORPHONE HYDROCHLORIDE INJECTION USP 2MG SOLUTION Resolved 2022-11-28 2022-12-29 176056
HYDROMORPHONE HYDROCHLORIDE INJECTION USP 2MG SOLUTION Resolved 2023-03-20 2023-04-13 187433
HYDROMORPHONE HYDROCHLORIDE INJECTION USP 2MG SOLUTION Resolved 2023-04-21 2023-05-09 190148
HYDROMORPHONE HYDROCHLORIDE INJECTION USP 2MG SOLUTION Resolved 2023-01-27 2023-03-06 182563
HYDROMORPHONE HYDROCHLORIDE INJECTION USP 1MG SOLUTION Resolved 2026-03-23 2026-03-31 281148
HYOSCINE BUTYLBROMIDE INJECTION SANDOZ STANDARD 20MG SOLUTION Resolved 2022-08-18 2022-12-14 167324
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Resolved 2021-08-23 2023-10-27 144424
IMIPENEM AND CILASTATIN FOR INJECTION USP 500MG 500MG POWDER FOR SOLUTION Resolved 2021-08-09 2021-08-16 143854
INCLUNOX 30MG SOLUTION Resolved 2022-03-10 2022-09-10 156458
INCLUNOX 60MG SOLUTION Resolved 2022-03-10 2022-10-22 156464
INCLUNOX 40MG SOLUTION Resolved 2022-03-10 2022-09-10 156461
INCLUNOX 80MG SOLUTION Resolved 2022-03-10 2022-10-22 156467
INCLUNOX 100MG SOLUTION Resolved 2022-03-10 2022-10-22 156455
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ANGIOMAX 250MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280590
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BORTEZOMIB FOR INJECTION SDZ 3.5MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280595
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265

Showing 1 to 20 of 136